The EU legislature has reached an agreement on the text of CS3D, which profoundly affects the ways companies active in Europe will manage their supply relationships and supply chains worldwide. Tune into this client alert to learn more.
bit.ly/3xw8JmZ

Join Partner Kirk J. Nahra (work) on 4/16 during Health Care Compliance Association (HCCA)® Compliance Institute. His session, “Key Challenges in Health Care Privacy,” will be broadcast live at 1:15 p.m. Register today bit.ly/43Z6ftI

WilmerHale advised Alethea, a leading technology company in disinformation detection and mitigation, in its recently announced closing of its $20 million Series B funding round. Learn more. bit.ly/3W0dZK1

In this latest blog post, Senior Associate Alice Lepeuple discusses the implications of the judgment in USA v Robertson for UK white-collar crime practitioners.
bit.ly/4d6BpUb

A team led by Chris Barnstable-Brown and Scott Lunin advised Eliem Therapeutics on its definitive merger agreement to acquire Tenet Medicines and on its concurrent private placement of common stock worth $120 million. Learn more about this transaction. bit.ly/49NFhXj

On May 9, join Partner Rosemary Reilly at the 2024 Convergence Forum where she will be speaking on the panel titled 'What Happens When Strategic Options Run Out.' Learn more and register.bit.ly/3vXRWsu

The Antitrust Division of the DOJ has quietly made a change to its Leniency Policy and Procedures that could impact companies involved in transactions. This client alert summarizes the change and provides practical implications for merging parties. wilmerhale.com/en/insights/cl…

WilmerHale lawyers Perry Lange, Nana Wilberforce, Lauren Ige and John O’Toole recently authored an article in Antitrust Magazine titled “The State of ‘No-Poach’ Prosecution: Is It Just Like Market Allocation After All?” Read their insights:
bit.ly/4cO0Klt

WilmerHale represented Seaport Therapeutics in connection with its spin-off from PureTech Health and its $100 million oversubscribed Series A financing round.
bit.ly/49CbfW1

In this IFA Magazine article, Counsel Imogen Makin comments on the FCA’s Business Plan for 2024-25 and its continued focus on reducing and preventing financial crime.
bit.ly/3UaxT3l

Our CFTC 2023 Year in Review and a Look Forward webinar has been postponed to April 18. Learn more and register here. bit.ly/3PC3XL7

WilmerHale joined several civil rights and legal organizations in an extraordinary petition to CA’s Supreme Court challenging the #deathpenalty as racially biased in violation of the state constitution’s Equal Protection Clause.
bit.ly/4aLjBM1

The opening weeks of spring have seen comprehensive privacy law proposals continue to progress in state legislatures across the country. To stay up to date on the latest state privacy law developments, please subscribe to our blog. bit.ly/3vUsELT

Xilio Therapeutics, Inc., recently announced its exclusive license agreement with Gilead Sciences for its tumor-activated IL-12 program, along with a concurrent private investment in PIPE financing. Learn more about this deal. bit.ly/43O1Euf

Join us on 4/16 for the latest webinar in our series 'The Revolution Will Be Synthesized,' exploring AI's transformative impact in the realm of financial services. Don't miss this opportunity to gain valuable insights on deploying AI in financial markets. bit.ly/3JhaOWp

Article 5 of the European Union’s Artificial Intelligence Act essentially prohibits #AI practices that materially distort peoples’ behavior or that raise serious concerns in democratic societies. Learn more in this blog post:
bit.ly/49w0apD

On 4/29, join WilmerHale Partners Neena Shenai and Zachary Goldman at ACI’s 18th Annual Conference on Economic Sanctions Enforcement and Compliance in Washington, DC. Learn more about their panels:
bit.ly/4al7GVr

.The Legal 500 has named Stephanie Evans, Hal Leibowitz and Joe Conahan to its 2024 US M&A Private Practice Powerlist, which recognizes the nation’s leading M&A practitioners whose experience, leadership and legal prowess distinguish them from their peers.
bit.ly/4apUgHS

In a new article for American Bar Association, Senior Associate Ali Jessani discusses Washington’s My Health My Data Act and details notable elements that companies should pay attention to as they evaluate how the law may impact their business. Read his insights:
bit.ly/3U3GG7m

WilmerHale submitted a SCOTUS amicus brief in support of the plaintiffs and on behalf of medical and public health professionals and organizations in Grants Pass v. Johnson, one of the most significant legal cases regarding homelessness in decades.
bit.ly/43LsoeQ